Create an Account

A decade of innovation, guidelines, and paradigm shifts in LDL-c management

Meeting report with slides, videos and CME course of a PACE-CME symposium at ESC 2022.

Episodes 1-4 of 4

  • LDLc new insights into its role as causal risk factor and target for therapyLDLc new insights into its role as causal risk factor and target for therapy
    A decade of innovation, guidelines, and paradigm shifts in LDL-c management
    LDL-c: new insights into its role as causal risk factor and target for therapy
    • Prof. Brian Ference, MD
      Prof. Brian Ference, MD

      Prof. Brian Ference, MD

  • Addressing the unmet needs in LDLc lowering what can we expectAddressing the unmet needs in LDLc lowering what can we expect
    A decade of innovation, guidelines, and paradigm shifts in LDL-c management
    Addressing the unmet needs in LDL-c lowering; what can we expect?
    • Prof. John Kastelein, MD
      Prof. John Kastelein, MD

      Prof. John Kastelein, MD

  • Targeting the PCSK pathway where do novel therapies fit inTargeting the PCSK pathway where do novel therapies fit in
    A decade of innovation, guidelines, and paradigm shifts in LDL-c management
    Targeting the PCSK9 pathway: where do novel therapies fit in?
    • Ann Marie Navar, MD, PhD
      Ann Marie Navar, MD, PhD

      Ann Marie Navar, MD, PhD

  • Changing paradigms in LDLc reductionChanging paradigms in LDLc reduction
    A decade of innovation, guidelines, and paradigm shifts in LDL-c management
    Changing paradigms in LDL-c reduction
    • Prof Kausik Ray
      Prof Kausik Ray

      Prof Kausik Ray

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We’re glad to see you’re enjoying PACE-CME…
    but how about a more personalized experience?

    Register for free
    You are now leaving PACE-CME and going to a site run by another organization.

    Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.